Brief: • USANA HEALTH SCIENCES PROVIDES PRELIMINARY FISCAL YEAR 2022 RESULTS AND ISSUES INITIAL FISCAL YEAR 2023 OUTLOOK
05/01/2023 21:53
Jan 5 (Reuters) - USANA Health Sciences Inc USNA.N :
* USANA HEALTH SCIENCES INC - SEES FY 2023 EPS $2.35 - $3.30
* USANA HEALTH SCIENCES PROVIDES PRELIMINARY FISCAL YEAR
2022
RESULTS AND ISSUES INITIAL FISCAL YEAR 2023 OUTLOOK
* USANA HEALTH SCIENCES INC SEES INITIAL FISCAL 2023
CONSOLIDATED
NET SALES $850 - $950 MILLION
Source text for Eikon: ID:
Further company coverage: USNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on USANA Health Sciences
See all newsBrief: Usana Schedules Third Quarter 2026 Earnings Release And Conference Call
Brief: Usana Health Sciences - Enters First Amendment To Credit Agreement On Sept 30, 2026 - SEC Filing
USANA Health Sciences Q2 sales fall amid weaker Hiya and Rise performance
Brief: USANA Health Sciences Q2 EPS USD -1.16
Usana Health Sciences Inc Expected To Post Earnings Of 43 Cents A Share: Earnings Preview